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Abstract 
Background: The Nature Step to Respiratory Health was the overarching theme of the 12th General Meeting of the 
Global Alliance against Chronic Respiratory Diseases (GARD) in Helsinki, August 2018. New approaches are needed 
to improve respiratory health and reduce premature mortality of chronic diseases by 30% till 2030 (UN Sustainable 
Development Goals, SDGs). Planetary health is defined as the health of human civilization and the state of the natural 
systems on which it depends. Planetary health and human health are interconnected, and both need to be consid‑
ered by individuals and governments while addressing several SDGs.
Results: The concept of the Nature Step has evolved from innovative research indicating, how changed lifestyle 
in urban surroundings reduces contact with biodiverse environments, impoverishes microbiota, affects immune 
regulation and increases risk of NCDs. The Nature Step calls for strengthening connections to nature. Physical activity 
in natural environments should be promoted, use of fresh vegetables, fruits and water increased, and consumption 
of sugary drinks, tobacco and alcohol restricted. Nature relatedness should be part of everyday life and especially 
emphasized in the care of children and the elderly. Taking “nature” to modern cities in a controlled way is possible but 
a challenge for urban planning, nature conservation, housing, traffic arrangements, energy production, and impor‑
tantly for supplying and distributing food. Actions against the well‑known respiratory risk factors, air pollution and 
smoking, should be taken simultaneously.
Conclusions: In Finland and elsewhere in Europe, successful programmes have been implemented to reduce the 
burden of respiratory disorders and other NCDs. Unhealthy behaviour can be changed by well‑coordinated actions 
involving all stakeholders. The growing public health concern caused by NCDs in urban surroundings cannot be 
solved by health care alone; a multidisciplinary approach is mandatory.
Keywords: Nature, Biodiversity, Immune regulation, Lifestyle, Respiratory diseases, Environment, Planetary health, 
CRDs, NCDs, SDGs
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Background
The 12th General Meeting of the Global Alliance against 
Chronic Respiratory Diseases (GARD) [1] was hosted by 
the Finnish Lung Health Association and the National 
Institute for Health and Welfare in Helsinki 30.8.-
1.9.2018. It covered the theme The Nature Step to Res-
piratory Health discussing the influence of nature and 
natural elements on respiratory health and on NCDs in 
general. Prevention and management of chronic respira-
tory diseases need a fresh approach, especially as new 
data concerning health effects of environment, lifestyle 
and indigenous microbiota have emerged since previous 
GARD meetings. The meeting gathered around 100 opin-
ion leaders from all continents and over 30 countries. It 
featured presentations on hot topics like environmental 
effects on respiratory health, determinants of immune 
balance and planetary health.
This paper outlines the recent findings in the area of 
improving contact with nature as a strategy for respira-
tory health and suggests action to combat the challenges 
of the modern world. To change our behaviour, we should 
first change our minds by adapting new knowledge [2].
The United Nations Sustainable Development Agenda 
2030 was formulated by world leaders in 2015 at a his-
torical summit in New York [3]. All countries were called 
to work on 17 sustainable development goals (SDGs) and 
end poverty, fight inequalities, tackle climate change and 
ensure that no one is left behind. These goals highlight 
that education, health, social protection, tackling climate 
change and restoring the natural resources of the Earth 
are important prerequisites to achieve economic balance 
and end poverty [4]. While the SDGs are not legally bind-
ing, governments and populations are urged to take own-
ership, show commitment, provide the necessary funding 
and monitor progress towards the goals within the time-
frame of 11 years, by the year 2030.
Over the last few decades, premature mortality from 
non-communicable diseases (NCDs) before age 70 has 
dropped in almost all countries [5]. However, additional 
efforts are needed to achieve a further reduction of 30% 
by 2030. SDG Goal No. 3 on Good health and wellbe-
ing promotes healthy living for all and lists a number of 
important targets to be achieved. For NCDs it aims to 
reduce premature mortality by one-third through pre-
vention and treatment, and promote mental health. SDG 
Goal No. 15 on Life on Land proposes we take care of our 
planet. This includes stopping deforestation, land deg-
radation and loss of animal and plant species, i.e. biodi-
versity loss. Contact with nature educates the human 
immune system and endorses tolerance against a vari-
ety of exposures being thus an essential determinant of 
health [6]. All the 17 goals are highly interconnected and 
in many cases progress in one depends on progress in 
some other goals. For example, biodiversity is a goal the 
progress of which several other goals depend on [7].
The concept of Nature Step
Urbanization and sedentary lifestyle
The world is urbanizing faster than ever, and the United 
Nations predicts that 68% of all human populations live 
in cities by 2050 [8]. At the same time many chronic con-
ditions including respiratory, allergic, autoimmune, met-
abolic and mental diseases, are on the increase worldwide 
in urban environments [9, 10]. The human immune sys-
tem has run into an adaptation crisis not having had time 
to adjust to the rapidly changing environment and life-
styles. Crucial elements in this context are the environ-
mental as well as our indigenous microbiota [11] (Fig. 1).
Urban living in asphalt-covered environments with 
little green space may not provide us with the diverse 
microbial stimulation necessary for the development of 
a balanced immune function. This is augmented by the 
use of highly processed food, salty and fatty food, sug-
ary drinks and alcohol and the lack of physical activity. 
Several chronic diseases mentioned above are linked to 
alteration in our indigenous microbiota and the disap-
pearance of ancient species from these commensal com-
munities [11].
Other environmental stressors like air pollution, com-
mon environmental chemicals, noise and behavioural 
changes like sedentary lifestyle add to the risks. Peo-
ple in urban settings spend more than 90% of their lives 
indoors. Sedentary lifestyle has indeed become a serious 
concern in modern societies [12]. The situation is par-
ticularly alarming among children. Recent observations 
link the lack of green surroundings to mental well-being 
and depression [13, 14]. The studies of residential sur-
rounding greenness and proximity to green spaces on 
respiratory and allergic symptoms are not uniform, but 
the majority shows benefits [15–20]. In a recent study, 
green areas around school neighbourhoods had an effect 
even on students´ lung function [21]. Interestingly, this 
effect was partially mediated by the autonomic nervous 
system. In a nationally representative cohort of 20,000 
subjects in England, at least 120 min weekly contact with 
natural environment was associated with good health 
and well-being [22].
Increasing surrounding greenness alone may be ineffec-
tive, if nutrition and physical activity remain unchanged. 
Moreover, green surrounding may be more of a surrogate 
marker of the lifestyle.
Biodiversity hypothesis
The 2018 Living Planet Report by the World Wildlife 
Fund gave a stunning message: “Wildlife populations 
show continuous decline, on average by 58% between 
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1970 and 2014 and are likely to reach 67% by the end of 
the decade” [23]. The human impact is overwhelming. 
According to the Intergovernmental Science-Policy Plat-
form on Biodiversity and Ecosystem Services (IPBES), 
75% of the land surface and 66% of the ocean area are sig-
nificantly altered [24]. Over 85% of wetlands have been 
lost.
Biodiversity loss may be the most dangerous meg-
atrend, along with interlinked global warming [25, 26] 
and air pollution [27]. In 2015, for the first time, the UN 
recognized biodiversity as an essential determinant of 
human health [9] and included it in Goal No. 15 of the 
SDG 2030 Agenda [3]. Biodiversity loss in the wider envi-
ronment was recognized to reduce diversity in human 
microbiota, contributing to immune dysfunction and dis-
ease. For example, environmental and lifestyle changes 
may affect microbial diversity of the fetal and infant gut 
microbiome impacting type I diabetes susceptibility [28].
The species on Earth are interlinked by complex 
interactions like antagonistic ones involving predation, 
herbivory and parasitism, or mutualistic ones, such as 
those involving the pollination of flowers by insects. 
Moreover, the metaphor hints that the interactions may 
be complex to the point of being impossible to fully elu-
cidate [29]. Biodiversity can be broadly defined as the 
variety of life on Earth. It includes the genes in all living 
cells, populations, species and their communities, the 
habitats in which they occur, and the ecosystems they 
comprise [30].
The biodiversity hypothesis proposes simply that bio-
diversity loss leads to immune dysfunction and disease 
[31]. Reduced contact of people with natural diverse 
environments, including microbiota, adversely affects the 
assembly, composition and quality of human commen-
sal microbiota and may thereby lead to inadequate and 
unbalanced stimulation of immunoregulatory circuits 
and ultimately to clinical disease [32–35].
The hypothesis is based on the concept that patho-
gen recognition receptor signalling and the regulatory 
network activation are needed throughout life for the 
balanced development and maintenance of immune reg-
ulation [6]. Beneficial effects of microbiota in the farm-
ing environment are known as it has been shown that 
children raised in farms with early life exposure to rich 
microbiota are protected against allergies and asthma 
[36–38]. However, the role of environmental microbi-
ota by and large has been less explored and recognized. 
Increased risk in the farming environment may be mas-
sive and sudden exposure to microbes causing allergic 
alveolitis or long term exposure to pesticides [39].
Fig. 1 Several non‑communicable diseases have been suggested to share the same underlying risk factors such as microbial imbalance, long‑term 
immune dysfunction and low‑grade inflammation
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Two layers of biodiversity
We are protected by two nested layers of biodiversity, con-
sisting of microbes residing in our bodies and those of the 
environment we live in [40]. The diversity and composi-
tion of the inner layer are dependent largely on microbial 
colonisation from the outer layer, a process that depends 
on our environment and behaviour. Microbes are also 
transferred vertically, from mother to child. This route of 
microbial colonization has been discussed in detail else-
where [41]. After a house move, the microbial commu-
nity in the new house rapidly converged on the microbial 
community of the occupants’ former house, suggesting 
colonization by the family’s microbiota [42]. To preserve 
our inner biodiversity—which closely interacts with the 
immune system—we need to preserve the outer biodiver-
sity and change our everyday practices. It is evident but 
poorly studied that everything we eat, drink, inhale and 
touch affects the composition and function of our micro-
biota and promotes a cross-talk of human DNA with the 
environmental metagenome [11, 43, 44].
The role of microbes in immune tolerance
During the last decade, human microbiota has become a 
central issue in health and disease. Microbes hold prom-
ise for new strategies of prevention and treatment of 
many inflammatory conditions [45, 46]. Altogether, sev-
eral factors have been identified to be involved in poorly 
developed or broken immune tolerance. These include 
lack of natural microbial exposure, especially in early 
and late life, dietary factors, dwelling and its surround-
ing, lifestyles and the use of antibiotics. Broken tolerance 
is discussed thoroughly elsewhere and not reiterated here 
[6].
The number of bacteria in the body is about the same 
as the number of our own cells [47]. Around 3 million 
genes are encoded in the genome of our microbiota, 
compared to around 20,000–23,000 genes of the human 
genome. The microbiome can be regarded as our second 
genome, to which we have externalized many protective 
and life supporting functions [48]. The gut microbiome 
is being attributed an important role in diseases such as 
obesity, diabetes and metabolic disease [49].
Many urban environments appear to lack elements 
such as plants and trees necessary for the proper devel-
opment of tolerance against foreign proteins [50]. Peo-
ple living in densely built urban areas are less exposed to 
diverse environmental microbiota than people living in 
more sparsely built areas [51]. A study comparing ado-
lescents in Finnish and more rural Russian Karelia [52] 
showed that the skin and nasal microbiome of the Finn-
ish and Russian adolescents were quite contrasting and 
directing immune responses to opposite routes [53]. The 
environmental microbiota may have profound effects on 
DNA methylation e.g. of CD14, which is a pattern-recog-
nition receptor for lipopolysaccharides (LPS) and other 
bacterial wall-derived components [54]. Epigenetic regu-
lation affects innate immune function and guides inflam-
matory pathways [55].
Cities are built and organized differently, and many 
have residential areas with a lot of green spaces. Practi-
cal actions for greener cities are increasing, and also pro-
moted by United Nations [56]. Also, the GSDR 2019 calls 
upon fostering urban citizens relationship with nature 
by promoting green space, urban biodiversity and urban 
food production [7]. At the same time, the idea of Smart 
Cities with environmental priority is one of the central 
themes to be funded by the new EU Programme, Horizon 
Europe 2021–2027 [57].
Nature Step in practice
The Nature Step is still a hypothesis, but suggests practi-
cal actions to improve nature relatedness by: (i) strength-
ening connections with natural environments and 
increasing physical activity, (ii) increasing use of fresh 
vegetables and fruits and water, avoiding sugary drinks 
and consumption of tobacco and alcohol, (iii) linking 
with natural elements especially in the care of children 
and the elderly, and (iv) focusing research also on ecosys-
tem services and their health effects to gain evidence to 
improve practices [58].
According to the World Health Organization (WHO), 
approximately 1.7 million (2.8%) of deaths worldwide 
are attributable to low fruit and vegetable consumption 
[59]. There is convincing evidence that consumption 
of high-energy foods, such as processed foods contain-
ing lot of fats and sugars, promotes obesity compared to 
low-energy foods such as fruits and vegetables, and even 
increase all-cause mortality [60]. The possible immuno-
logical effect of soil microbes in fresh food is a research 
priority, as in a recent mouse model study soil exposure 
modified the gut microbiota and supported immune 
tolerance [44]. Other research priorities in the field of 
chronic respiratory and allergic diseases have been out-
lined in a 2010 GARD publication [61].
At the urban society level, there is no return to the tra-
ditional farming life, but it is possible to integrate ele-
ments of nature into modern cities in a controlled way 
and foster the contact of humans and green elements 
through policy and practice. That is a challenge for pol-
icy makers responsible for city planning, housing, traffic 
arrangements, supplying energy, education, social ser-
vices and especially for food production and distribution. 
Healthy behaviour may also be promoted by introduc-
ing taxes on unhealthy foods and sugary drinks, tobacco 
and alcohol. The impact of this approach on respiratory 
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health and other NCDs—and reduction in health care 
costs—is a research priority.
While many of the points included in the Nature Step 
approach are part of the best buys strategy of the WHO 
to reduce the burden from NCDs, better understand-
ing of the mechanisms of nature connection leading to 
interventions is needed to obtain evidence for societal 
actions. People must become aware that the link with 
nature is critical for their own health as well as for their 
communities.
The Finnish Programme showing the way
The Finnish Allergy Programme (2008–2018) revis-
ited the allergy and asthma paradigm and led to actions 
relevant to society and healthcare as a whole [62, 63]. 
Immune tolerance and allergy health were promoted 
through a Nature Step in trying to reset the connection 
between humans and the natural environment, the origi-
nal home of Homo sapiens (Fig. 2). There is some direct 
evidence indicating that human microbiota can be mod-
ulated by nature contact, i.e. by handling soil and plant-
based materials [64].
In Finland, the burden of allergy and asthma has started 
to decline and there is less medicalisation, less allergy 
diets, and the severity of asthma has decreased. For 
example, in 2013–2015, the prevalence of use of allergy 
diets decreased by 43% in day care centres in the Helsinki 
Capital area [65]. The Finnish disease surveillance sys-
tem is showing signs that the epidemic is slowing down 
as the asthma and allergic rhinitis prevalence is levelling 
Fig. 2 The Nature Step to Respiratory Health
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off [66]. Experience shows that medical communities and 
societies can lessen the disability and costs caused by 
these disorders and improve public health.
Actions taken for allergy and asthma may also show 
the way to prevent many other NCDs which are on the 
rise everywhere in urban communities. An educational 
programme tackling diabetes, obesity and inflamma-
tory bowel diseases, in addition to allergy and asthma, is 
planned to take off in Finland in 2020 [28, 67]. A Nature 
Step is also undertaken in day-care, where (i) diet is 
changed (less meat and more fresh fruits and vegetables), 
(ii) food waste is minimized, and (iii) connection to natu-
ral environments is increased. The project starts in 2019 
and is funded by The Finnish Innovation Fund SITRA 
[68].
The Finnish Allergy Programme (2008–2018) imple-
mented Nature Step both for primary and secondary (ter-
tiary) prevention of allergy and asthma by emphasizing 
nature relatedness. Promoting physical exercise, reducing 
air pollution and stopping smoking were also central.
Human and planetary health—the grand 
challenges
Planetary health and global warming
According to recent projections, changes in climate will 
increase in the coming years [69]. Global warming rep-
resents a massive threat also to respiratory health by 
directly promoting or aggravating respiratory diseases, 
and by increasing exposure to risk factors [70]. Warming 
increases the exposure to pollen, allergens produced by 
plants, mould proliferation, ambient air ozone and par-
ticulate matter at ground level. The main respiratory con-
cerns are allergic respiratory diseases, asthma, chronic 
rhinosinusitis (CRS), chronic obstructive pulmonary 
disease (COPD) and respiratory tract infections. Groups 
at higher risk of global warming include individuals with 
existing cardiopulmonary diseases or disadvantaged indi-
viduals. Adaptation and mitigation measures are needed.
Climate affects weather, air and water quality, local 
and national water and food supplies, economics and 
other critical health determinants. Observational evi-
dence indicates that regional temperature increases affect 
a diverse set of physical and biological systems in many 
parts of the world, some of which are of concern for res-
piratory health. A rapid rise has been observed in the 
number of hot days, such as the 2003 heat wave result-
ing in 40,000 excess deaths across Europe, mostly for 
cardiopulmonary causes [71]. In 2018 another heat wave 
was experienced in many parts of the world, the effects of 
which have not been calculated yet. On the other hand, 
nature based solutions can help humans to adapt to heat 
waves in cities, e.g. by providing shelter in the form of 
trees [72].
In 2015, the report of a commission on planetary 
health created by the Lancet Commission and the Rock-
efeller Foundation proposed a new way of understanding 
the relationship between human health and the environ-
ment [73]. The view emerged from the realization that 
humanity is experiencing substantial improvements in 
life expectancy and health at a time when many ecosys-
tems worldwide are degrading at unprecedented rates. 
Wealthy populations can use ecosystem services from 
other locations through access to markets widening 
health and ecological inequalities. The dependence of 
health on ecosystems is delayed and complex enough not 
to be detected with our current paradigms and methods 
[74, 75]. The current concept of health does not take into 
account whether health gains are achieved at the cost 
of eroding the Earth’s underpinning natural systems. To 
reconcile human health with the restauration of planet’s 
natural resources, Planetary Health is seen as the high-
est attainable standard of health and wellbeing; i.e. taking 
into account Earth’s natural systems limits within which 
humanity can flourish [73].
Air pollution
Ambient air pollution is a heavy burden in many indus-
trialized and developing countries, especially in urban-
ized areas where it contributes to increased morbidity 
and mortality [76]. More than 90% of air pollution related 
deaths occur in low and middle-income countries 
According to WHO estimates, outdoor air pollution 
caused about 4.2 million deaths in 2016 and indoor air 
pollution from cooking with polluting technologies 3.8 
million deaths in the same year [77]. As reported by the 
Lancet Commission on pollution and health, the global 
estimated annual deaths due to pollution risk factors 
ranges between 8.4 (according to the WHO best esti-
mate) and 9.0 million (Global Burden of Diseases best 
estimate) [78].
Lungs and the cardiovascular system are affected by 
exposure to fine and ultrafine particles in polluted air, 
causing stroke, heart disease, cancer, COPD and respira-
tory infections such as pneumonia [79]. A joint ERS/ATS 
policy statement of the adverse effects of air pollution has 
been recently published [80]. Outdoor air pollution is a 
risk factor for asthma and COPD emergency visits [81, 
82], and sleep apnoea [83].
For allergy and asthma, immune dysfunction poses 
the main risk, but heavy air pollution also contributes 
to inflammation and affects immune regulation, e.g. die-
sel fumes may promote allergic inflammation [84]. Epi-
demiological studies in Japan showed that the increase 
in cedar pollinosis was likely linked to Diesel exhaust 
[85]. Other outdoor air pollutants are associated with 
increased frequency of asthma exacerbations as well as 
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symptoms that affect quality of life such as cough, wheez-
ing and nasal drainage [86]. Nevertheless, there are sit-
uations like in Finland where ambient air pollution is 
minimal, even in cities, still asthma prevalence is high 
[87].
Smoking
Tobacco use is the main risk factor for all major NCDs. 
It is estimated by WHO that the tobacco epidemic kills 
more than 7 million people a year. Six million of these 
deaths are due to direct tobacco use and about 900,000 
due to second-hand smoke [88].
For COPD and lung cancer, smoking is overwhelmingly 
the greatest risk, which is augmented by air pollutants. 
Global efforts for implementing the Framework Conven-
tion on Tobacco Control and using the WHO MPOWER 
package have led to better policies in tobacco control [89, 
90]. In many countries, however, additional efforts are 
needed to achieve the UN Sustainable Goals. Moreover, 
since use of electronic cigarettes has rapidly escalated 
among youths and are strongly associated with the subse-
quent initiation of combustible tobacco products, control 
strategies at the national level are mandatory [91].
Furthermore, oriental water pipe (Narghile) smok-
ing is alarmingly increasing in Europe and the Americas 
and becoming a pandemic [92]. The WHO Framework 
Convention on Tobacco Control Secretariat has worked 
to establish a network of six knowledge hubs for the 
tobacco MPOWER programme within academic institu-
tions. Water pipe and smokeless tobacco use is one of the 
six hubs. Each of them specializes in a given area, such 
as taxation or research and surveillance, and assists par-
ties in their implementation work and disseminating 
information.
Endgame for smoking
Of particular interest are tobacco endgame policies 
adopted by a few countries including Finland [93, 94]. 
The goal of the Tobacco-free Finland 2030 Network is to 
create a tobacco- and nicotine-free country [95]. In 2010, 
23% of Finnish men and 16% of women smoked. Instead 
of restricting the harmful effects of smoking, the goal 
of the Tobacco Act aimed to end the consumption of 
tobacco products in Finland by the year 2030.
In 2012, Finnish sales outlets were prohibited from 
displaying tobacco products. In 2014, the European 
Union passed the updated Tobacco Products Directive 
(2014/40/EC) stipulating that tobacco packaging must 
include health warnings containing image and text.
In 2015, 16% of Finnish men and 12% of women 
smoked. In 2016, the updated version of the Tobacco 
Act came into force. In 2020, the aim is to ban menthol 
as a flavouring of tobacco products. In 2030, when the 
objective of the Tobacco Act is hopefully met, less than 
5% of the adult population should consume tobacco or 
nicotine products on a daily basis.
Under the framework of planetary health, fight against 
smoking and air pollution provides an opportunity to 
work both to protect human health and restore the natu-
ral resource of the Planet. For air pollution there is abun-
dant evidence that active transportation policies can 
reduce greenhouse gas emissions and improve air quality 
and physical exercise [96]. In a similar way, eradication of 
smoking could not only result in unprecedented health 
benefits but also in reduction of deforestation and land 
degradation as well as in improvements of biodiversity in 
large tobacco production areas [97]. Recent studies have 
shown that vaping is also representing a risk for morbid-
ity and mortality and needs to be urgently regulated [98].
Future challenges
The epidemic of chronic respiratory diseases and other 
NCDs is the result of changes in lifestyle including 
reduced contact to natural environments, tobacco smok-
ing and outdoor/indoor air pollution and unhealthy diets. 
Indoor life in buildings, reduced physical activity, diets 
using processed food and excessive meat consumption 
rather than plant-based diets [99, 100], sugary drinks, 
tobacco and alcohol [101] contribute to the risk. The rela-
tive importance of each of these factors varies between 
populations and living conditions, but they are all mainly 
caused by exponential growth of human populations 
leading to escalating urbanization worldwide.
Global, national and local action plans taking into 
account the local situation need to be constructed and 
implemented by engaging policy makers, governments, 
civil society and each individual. This will lead to a bet-
ter understanding regarding the benefits of positive Steps 
living in and with Nature (Fig. 3).
Monitoring of the different determinants in urban sur-
rounding and their effects on microbiome and immune 
regulation is difficult and only little studied. Basic ques-
tions remain unanswered. For example, what happens 
when we pick up a wild berry from the bush to the 
mouth? What is the microbiota of the berry, how does it 
transfer to our hands and skin, how to the mouth and gut, 
and how does it modulate human microbiota and regu-
late the immune system? If eating wild berries, “super-
food”, reduces disease risk, by what mechanism? What 
is the dynamics of environmental microbiota affecting 
human microbiota? What is the composition of “healthy” 
human microbiota and what are the mechanisms of the 
cross-talk with human cells and gene expression? For 
example, Sberro et al. found recently thousands of previ-
ously unknown small proteins in the human microbiome, 
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which may perform diverse functions including epige-
netic modulation [102].
Furthermore, how are human microbiota affected by 
different diets, antibiotics or chemicals? What are the 
most important urban/rural microbial determinants 
influencing risk of NCDs, and what, altogether, is the 
relative importance of environment/lifestyle factors and 
hereditary dispositions? Is it possible partly to compen-
sate the “lost nature connection” with artificial microbial 
supplementation? New information is urgently needed, 
and we strongly advocate both for controlled and real-life 
studies.
The logistic regression models to assess air pollution 
effects should be supplemented by biodiversity infor-
mation, at least by land use data. Usually, air pollution 
effects are seen in big cities where biodiversity loss is also 
at its worst. Their interaction and confounding effects 
should be investigated in future epidemiological studies. 
Altogether, the respiratory effects of biodiversity loss and 
global warming may be enormous but have been insuf-
ficiently evaluated [31].
A large proportion of NCDs is preventable and 
changes in behaviour modify disease severity and out-
come. This has been shown in Finland, where several 
successful public health programmes for chronic res-
piratory conditions and cardiovascular disease preven-
tion have been implemented [103, 104]. In terms of air 
pollution, the Vilnius Declaration originating from a 
meeting by the European Forum for Research and Edu-
cation in Allergies and Airway Diseases (EUFOREA) in 
March 2018 proposes several urgent actions to miti-
gate air pollution [105]. More recently, on September 
2018, the United Nations High-level Meeting on Non-
communicable Diseases has issued a declaration [106], 
in which the role of air pollution is outlined as a major 
risk factor to be combatted. Following this path, WHO 
has organized the First Global Conference on Air Pollu-
tion and Health, October 2018 [107].
While there is plenty of evidence that NCDs are pre-
ventable through policy changes such as tax increases 
for tobacco, unhealthy foods and drinks and individual 
behaviour change, implementing these measures is chal-
lenging as there is lack of funding for prevention pro-
grammes and opposition from industries with vested 
interests.
All governments need to address the health effects of 
major environmental threats on a regular basis to prompt 
timely and concrete actions. Indeed, the WHO 12th 
recommendation from the Declaration of the Health of 
People, Health of Planet and Our Responsibility: Climate 
Change, Air Pollution and Health Workshop 2017 states 
“Promote an alliance with society that brings together 
scientists, policy makers, healthcare providers, faith/spir-
itual leaders, communities, and foundations to foster the 
societal transformation necessary to achieve our goals in 
the spirit of Pope Francis’s encyclical Laudato si” [108].
Fig. 3 Imperative actions to promote human health and conserve nature
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The present paper is of importance to sustain Planetary 
Health and should be embedded in next-generation care 
pathways for respiratory diseases [109] for a change man-
agement strategy concerning CRDs [110]. On December 
3–4, 2019, a high-level meeting will be organized during 
the Finnish Presidency of the EU Council to discuss the 
impact between Planetary and Human health. A focus 
will be made concerning biodiversity and the digital 
transformation of health.
Conclusive remark
New research suggests that reducing harmful exposures 
and strengthening immune tolerance could be promoted 
through a Nature Step, resetting the connection between 
humans and nature. This is also an imperative for nature 
conservation and safeguarding a peaceful planet.
The most urgent challenge is for the quickly urbanis-
ing developing countries as their NCDs epidemic is quite 
recent and worsening, and effective strategies for preven-
tion and treatment have not been implemented. The pace 
of urbanization is fastest in Africa and South-East Asia, 
the exposure to nature in these populations is expected 
to fall dramatically [8].
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